Resultados de la búsqueda 1091-1100 of 6025 for Rebound+insomnia

  1. Oncología (médica) - Ensayos clínicos

    Rochester, Minn., Jacksonville, Fla. The purpose of this study is to to bring molecular risk prediction for breast cancer into the clinical arena through: the ...

  2. Hematología - Ensayos clínicos

    The purpose of this study is to compare the effects, good and/or bad of two treatment methods on subjects and their cancer. Proton beam radiation therapy is one ...

  3. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to design, develop and assess the performance characteristics of NGS assays using circulating tumor DNA for the detection of ...

  4. Neurología - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of the Pediatric Proton Consortium Registry (PPCR) is to enroll children who have been treated with proton radiation in the United ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival ...

  6. Radiología - Ensayos clínicos

    Rochester, Minn. The primary purpose of this study is to compare the diagnostic utility of 7T MRI versus 3T MRI in the detection of subtle epileptogenic lesions ...

  7. Amnesia global transitoria - Síntomas y causas - Mayo Clinic

    La amnesia total transitoria no tiene complicaciones directas. No es un factor de riesgo para tener un accidente cerebrovascular o epilepsia. Es posible tener ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...

  9. Oncología (médica) - Ensayos clínicos

    This is a Phase 2 global, multi-center, open-label study to assess the efficacy, safety and tolerability of AZD0486 monotherapy in adult participants with ...

  10. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia ...